$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The efficacy and role of adagrasib: Why is it a new hope in the treatment of lung cancer?
2026-02-01 22:25:32
Check Details
Which generation of EGFR-targeting drugs does afatinib belong to? Differences from other targeted drugs
2026-02-01 22:25:32
Check Details
Do I need to take Dalilaysan tablets for a long time? Treatment course and analysis of consequences of drug discontinuation
2026-02-01 22:25:32
Check Details
Is Lynparib/Olaparib a targeted drug or a chemotherapy drug? Comprehensive analysis of the mechanism of action
2026-02-01 22:25:32
Check Details
How much does a box of 2025 Venetoclax/Venetoclax cost? The latest prices and medical insurance reimbursement status
2026-02-01 22:25:32
Check Details
Can Aceminib cure chronic myelogenous leukemia? Analysis of efficacy and limitations
2026-02-01 22:25:32
Check Details
How much does ritexitinib cost in China? The latest prices and medical insurance coverage in 2025
2026-02-01 22:25:32
Check Details
What kind of medicine is sparsentan/sparsentan? What diseases is it suitable for?
2026-02-01 22:25:32
Check Details
Ixazomib/Enleri capsules: a new option for patients with multiple myeloma
2026-02-01 22:25:32
Check Details
Canafenib/cetuximab plus chemotherapy drives ORR improvement in BRAF V600E+ mCRC
2026-02-01 22:25:32
Check Details
Which generation of targeted drug is sotorasib? The development history of targeted therapy
2026-02-01 22:25:32
Check Details
How much does Adagrasib cost per month? Interpretation of treatment costs and medical insurance policies
2026-02-01 22:25:32
Check Details
1
2
...
1385
1386
1387
1388
1389
1390
1391
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure